Previous 10 | Next 10 |
2023-12-10 06:56:00 ET What are some unstoppable stocks to buy right now? Three Fool.com contributors think they've found three stocks that qualify -- and they're all in the healthcare sector. Here's why they picked Axsome Therapeutics (NASDAQ: AXSM) , Eli Lilly (NYSE: LLY) ...
2023-12-08 15:32:21 ET Summary Invesco S&P 500® Momentum ETF is invested in 100 stocks of the S&P 500 index with higher volatility-adjusted return. The SPMO ETF is less concentrated in technology but more concentrated in the top 10 holdings compared to the S&P 500...
2023-12-08 15:00:12 ET More on the markets S&P 500: New All-Time Highs Before A Major Sell-Off S&P 500 Forecast 2024: Muddling Through Only Thing That Matters Is Price; Nasdaq Has Further To Go - Cestrian Capital Research Money market funds attract mo...
2023-12-08 11:38:14 ET More on Eli Lilly Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly Eli Lilly and Company (LLY) Presents at 6th Evercore ISI HealthCONx Conference (Transcript) Eli Lilly: Perfectly Priced Healthcare Giant ...
Lilly Announces 15% Dividend Increase, First-Quarter 2024 Dividend PR Newswire INDIANAPOLIS , Dec. 8, 2023 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has announced a 15% increase in its quarterly dividend and declared a dividend for the f...
2023-12-08 10:10:20 ET Summary Nasdaq and S&P 500 gained nearly 5% in the last month, boosting investor optimism ahead of the NFP report. Job openings fell to lows not seen since March 2021, indicating a potential recession in 2024. The November NFP report showed a lower-t...
2023-12-08 05:30:00 ET Novo Nordisk (NYSE: NVO) is a leader in the billion-dollar weight loss market, with two drugs that have helped its earnings soar. The company sells semaglutide under the name Wegovy for weight loss and as Ozempic for type 2 diabetes. Doctors also have pres...
2023-12-07 23:57:14 ET Summary MoonLake Therapeutics is a clinical-stage biopharmaceutical company developing nanobody-based therapies for inflammatory diseases. Their lead product candidate, Sonelokimab, has shown best-in-class potential in treating Hidradenitis suppurativa and P...
2023-12-07 08:30:00 ET Growth stocks can make for great long-term investments. But the more attractive the growth stock, the higher the premium it normally commands. Just look at Nvidia , which is developing chips to help in the development of artificial intelligence models. Then there'...
2023-12-07 05:50:00 ET Many investors have flocked to big pharma stocks throughout the years. And doing so has paid off handsomely with several of those stocks. AbbVie (NYSE: ABBV) and Eli Lilly (NYSE: LLY) stand out as two of the biggest pharma stocks around. Both have ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 07:07:00 ET If your portfolio doesn't have exposure to the biopharma businesses pursuing the development of weight loss medicines, it might be time to consider changing that situation. With an influx of new drugs for sale, and many competitors looking to secure their share of the...
2024-07-30 05:48:00 ET Going into 2024, DexCom 's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from individuals with diabetes. However, last week was the worst for De...
2024-07-29 15:13:21 ET Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics Inc and Roche Holding AG, who made announcements regarding th...